Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-08-26

Clinical Trial Update: High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on using high-intensity focused ultrasound ablation to treat progressive prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University College London Hospitals | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN